SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BRADLEY PHARMACEUTICALS (BPRXA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John M. Bozeman who wrote (17)12/5/1996 4:37:00 PM
From: Brad Glassma   of 41
 
DEAR MR. BOZEMAN,

I THINK THAT YOU HAVE ASKED A VERY GOOD QUESTION. IT IS OUR BELIEF

THAT SURVIVING THE PAST YEAR WAS QUITE AN ACCOMPLISHMENT. GIVEN THE
FACT OF OUR TERRIBLE YEAR IN 1995 BECAUSE OF CHARGEBACKS IN THE
HEALTHCARE INDUSTRY. IT WAS SOMETHING THAT HAS HAPPENED TO MANY
OTHER COMPANIES AFTER US. COMPANIES LIKE MYLAN,ALPHARMA,IVAX,ROBERTS
AND ALSO MOST RECENTLY FORREST LABORATORIES. WE WENT THROUGH OUR
TOUGH PERIOD AND ARE NOW SEEING THE RESULTS OF ALL THE WORK THAT
WE HAVE DONE TO GET BETTER PRICES, IMPROVING THE FLOW OF
INFORMATION FROM AS LONG AS 4 TO 5 MONTHS DOWN TO TODAYS WHERE 85%
OF OUR CHARGEBACKS COME WITHIN 3 WEEKS OF THE EVENT. QUITE AN
IMPROVEMENT.

THE COMPANY HAS ACQUIRED VERY GOOD PRODUCTS AND WE ARE SEEING GROWTH
IN MANY OF THESE PRODUCTS. THE COMPANY ALSO DISTRIBUTES IN 25
COUNTRIES AROUND THE WORLD.AND IS VERY EXCITED ABOUT THE UPCOMING
COUGH/COLD/FLU SEASON WHICH WILL BE SPEARHEADED BY DECONAMINE--OUR
LEADING PRODUCT.

DANIEL GLASSMAN
CHIEF EXECUTIVE OFFICER
BRADLEY PHARMACEUTICALS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News